Finished
Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:
NCT06135233 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated 18 Nov 2023
- What is being tested
- No intervention
- For
- Pancreas Disease
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 1,336 people. The full rules are on the registry page.
- Where
- Netherlands
- When
- Starts or started 1 Jan 2019, ends 1 Jan 2022. Registered 18 Nov 2023.
- Results
- None posted yet.
In the researchers' words
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
Sites
- Amsterdam UMC, locatie AMCAmsterdam, North Holland, Netherlands